BEIJING: Pharmaceuticals made overseas, including cancer drugs and traditional Chinese medicines, will be exempt from import taxes starting May 1, as part of a package of polices to improve drug access and public health in China.
The move comes just over a week after the central government released measures to boost the production and clinical application of generic drugs to help lower the cost of medical bills.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
